News from our Partners

22 Apr 13	Lundbeck introduces Selincro for alcohol dependence
28 Aug 12	Pascal Soriot appointed Chief Executive Officer of AstraZeneca
27 Aug 12	MEDA: Zyclara approved in the EU
22 Jun 12	AstraZeneca: Zinforo receives positive CHMP opinion in the EU
24 May 12	Merck Serono Supports 4th International Thyroid Awareness Week
04 May 12	MEDA: Dymista could be drug of choice
18 Nov 11	Merck Serono: CHMP positive opinion for Rebif for patients with early signs of Multiple Sclerosis
11 Nov 11	Lundbeck and Otsuka sign agreement to deliver innovative medicines for psychiatric disorders
28 Oct 11	MEDA: Dymista filed in Europe
14 Oct 11	Recordati: Arrigo Recordati International Prize for Scientific Research awarded to Lindsey Allane
23 Jun 11	MEDA: Zyclara filed in Europe
23 May 11	Merck Serono supports for the third year the International Thyroid Awareness Week
04 Apr 11	Lundbeck: Sycrest roll-out starts with the launch of the product in the important European region
07 Mar 11	AstraZeneca and Galderma enter into R&D collaboration to develop new treatments for dermatological diseases